Aliases & Classifications for Arthritis

MalaCards integrated aliases for Arthritis:

Name: Arthritis 37 12 72 28 51 40 3 41 14 69
Inflammatory Joint Disease 51 69
Inflammatory Disorder of Joint 12

Classifications:



External Ids:

Disease Ontology 12 DOID:848
MeSH 41 D001168
NCIt 46 C2883

Summaries for Arthritis

MedlinePlus : 40 If you feel pain and stiffness in your body or have trouble moving around, you might have arthritis. Most kinds of arthritis cause pain and swelling in your joints. Joints are places where two bones meet, such as your elbow or knee. Over time, a swollen joint can become severely damaged. Some kinds of arthritis can also cause problems in your organs, such as your eyes or skin. Types of arthritis include Osteoarthritis is the most common type of arthritis. It's often related to aging or to an injury. Autoimmune arthritis happens when your body's immune system attacks healthy cells in your body by mistake. Rheumatoid arthritis is the most common form of this kind of arthritis. Juvenile arthritis is a type of arthritis that happens in children. Infectious arthritis is an infection that has spread from another part of the body to the joint. Psoriatic arthritis affects people with psoriasis. Gout is a painful type of arthritis that happens when too much uric acid builds up in the body. It often starts in the big toe. NIH: National Institute of Arthritis and Musculoskeletal and Skin Diseases

MalaCards based summary : Arthritis, also known as inflammatory joint disease, is related to juvenile rheumatoid arthritis and rheumatoid arthritis, systemic juvenile, and has symptoms including joint stiffness, sciatica and muscle cramp. An important gene associated with Arthritis is TNF (Tumor Necrosis Factor), and among its related pathways/superpathways are Innate Immune System and ERK Signaling. The drugs Rayos and Methotrexate have been mentioned in the context of this disorder. Affiliated tissues include joint, skin over the joint and bone, and related phenotypes are Decreased Tat-dependent HIV-LTR-beta-galactosidase protein expression and homeostasis/metabolism

Disease Ontology : 12 A bone inflammation disease that involves a response to irritation or injury, characterized by joint pain, swelling, stiffness located in joint and/or redness located in skin over the joint.

CDC : 3 Arthritis affects 54.4 million US adults, more than 1 of 4. It is a leading cause of work disability in the United States and one of the most common chronic conditions in the nation. Arthritis is a common cause of chronic pain.  

Wikipedia : 72 Arthritis is a term often used to mean any disorder that affects joints. Symptoms generally include... more...

Related Diseases for Arthritis

Diseases in the Arthritis family:

Transient Arthritis

Diseases related to Arthritis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 1336)
# Related Disease Score Top Affiliating Genes
1 juvenile rheumatoid arthritis 35.0 IL1B IL6 LTA TNF
2 rheumatoid arthritis, systemic juvenile 34.8 IL6 LACC1 MIF
3 reactive arthritis 34.7 IL17A IL6 TNF
4 systemic onset juvenile idiopathic arthritis 34.5 IL1B TNF
5 oligoarticular juvenile idiopathic arthritis 34.3 MIF PTPN22 TNF
6 psoriatic arthritis 34.3 IL17A IL1A IL1B LTA MMP1 MMP3
7 spondyloarthropathy 1 34.0 IL17A MMP3 TNF TNFSF11
8 polyarticular onset juvenile idiopathic arthritis 33.9 TNFRSF11A TNFSF11
9 rheumatoid lung disease 33.2 IL17A MMP3 TNF
10 adult-onset still's disease 33.1 CSF1 IL1B IL6 MIF TNF
11 palindromic rheumatism 33.1 IL1B PTPN22 TNF
12 osteoarthritis 32.9 CXCL8 IL1B IL6 MMP1 MMP13 MMP3
13 lyme disease 32.8 IL17A IL1B IL6 TNF
14 rheumatoid arthritis 32.7 CCL2 CSF1 CXCL8 IL17A IL1A IL1B
15 psoriasis 32.6 CCL2 CXCL8 IL17A IL1A IL1B IL6
16 temporal arteritis 32.6 CCL2 IL6 PTPN22
17 rheumatoid nodulosis 32.6 MMP3 MMP9
18 scleritis 32.6 CCL2 MMP9 TNF
19 brucellosis 32.5 CXCL8 IL6 TNF
20 rosacea 32.5 IL6 MMP9 TNF
21 paget's disease of bone 32.5 CSF1 TNFRSF11A TNFSF11
22 joint disorders 32.5 CSF1 IL17A IL1B IL6 MMP3 TNF
23 familial mediterranean fever 32.4 IL1B SAA1 TNF
24 bronchiolitis obliterans 32.3 CXCL8 IL17A IL6 MMP9 TNF
25 systemic lupus erythematosus 32.3 CCL2 CSF1 IL17A IL1B IL6 LTA
26 multicentric reticulohistiocytosis 32.3 CSF1 TNFSF11
27 behcet syndrome 32.2 CXCL8 IL17A IL1B IL6 LTA TNF
28 interstitial lung disease 32.1 CCL2 CXCL8 IL1A IL1B IL6 MMP9
29 osteoporosis 32.0 CSF1 IL1A IL1B IL6 TNF TNFRSF11A
30 sarcoidosis 1 31.9 CCL2 IL1B LTA MIF TNF
31 spondylitis 31.6 IL17A IL6 LTA TNF
32 uveitis 31.4 CCL2 IL17A IL1A TNF
33 spondyloarthropathy 31.3 IL17A IL6 MMP3 TNF TNFSF11
34 chlamydia 31.2 CXCL8 IL1B IL6 TNF
35 pneumonia 31.1 CCL2 CXCL8 IL1B IL6 TNF
36 pericarditis 31.0 IL1B IL6 TNF
37 synovitis 31.0 CXCL8 IL1B IL6 MMP1 MMP13 MMP3
38 chikungunya 31.0 IL1B IL6 TNF
39 lung disease 31.0 CCL2 CXCL8 IL1B MMP9 TNF
40 glomerulonephritis 31.0 CCL2 CSF1 IL1B MIF
41 anterior uveitis 31.0 IL6 PTPN22 TNF
42 crohn's disease 30.9 IL1B IL6 LACC1 TNF
43 osteomyelitis 30.9 CXCL8 IL1A IL1B IL6 TNF TNFSF11
44 pyoderma 30.9 CXCL8 MMP1 TNF
45 autoimmune disease 30.9 IL17A IL1B IL6 PTPN22 TNF
46 fasciitis 30.8 CXCL8 IL6 TNF
47 colitis 30.7 CXCL8 IL17A IL1B IL6 LACC1 TNF
48 kawasaki disease 30.7 CCL2 IL6 MMP3 MMP9 TNF
49 ischemic heart disease 30.6 CCL2 IL6 TNF
50 endocarditis 30.6 CXCL8 IL6 TNF

Graphical network of the top 20 diseases related to Arthritis:



Diseases related to Arthritis

Symptoms & Phenotypes for Arthritis

UMLS symptoms related to Arthritis:


joint stiffness, sciatica, muscle cramp, metatarsalgia, back pain, arthralgia

GenomeRNAi Phenotypes related to Arthritis according to GeneCards Suite gene sharing:

25
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Decreased Tat-dependent HIV-LTR-beta-galactosidase protein expression GR00224-A-2 8.8 IL1A MMP13 MMP9

MGI Mouse Phenotypes related to Arthritis:

43
# Description MGI Source Accession Score Top Affiliating Genes
1 homeostasis/metabolism MP:0005376 10.31 CSF1 IL17A IL1A IL1B IL6 LTA
2 immune system MP:0005387 10.27 TNFSF11 CCL2 CSF1 IL17A IL1A IL1B
3 hematopoietic system MP:0005397 10.25 LTA MIF MMP3 MMP9 PTPN22 TNF
4 endocrine/exocrine gland MP:0005379 10.11 CSF1 IL17A IL6 LTA PTPN22 TNF
5 integument MP:0010771 9.97 CSF1 IL1A IL1B IL6 MMP13 MMP9
6 neoplasm MP:0002006 9.81 IL1A IL1B IL6 MIF MMP1 MMP9
7 limbs/digits/tail MP:0005371 9.8 CSF1 LTA MMP13 MMP9 TNF TNFRSF11A
8 respiratory system MP:0005388 9.65 LTA MMP9 PTPN22 TNF TNFAIP6 TNFRSF11A
9 skeleton MP:0005390 9.36 MMP9 TNF TNFRSF11A TNFSF11 CSF1 IL17A

Drugs & Therapeutics for Arthritis

FDA approved drugs:

# Drug Name Active Ingredient(s) 17 Company Approval Date
1
Rayos 17 PREDNISONE Horizon Pharma July of 2012

Drugs for Arthritis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 978)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Methotrexate Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 1959-05-2, 59-05-2 126941
2
Abatacept Approved Phase 4,Phase 3,Phase 2,Phase 1 332348-12-6 10237
3
Adalimumab Approved Phase 4,Phase 3,Phase 2,Phase 1 331731-18-1 16219006
4
Etanercept Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 185243-69-0
5
Infliximab Approved Phase 4,Phase 3,Phase 2,Phase 1 170277-31-3
6
rituximab Approved Phase 4,Phase 3,Phase 2,Phase 1 174722-31-7 10201696
7
Leflunomide Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 75706-12-6 3899
8
Hydroxychloroquine Approved Phase 4,Phase 3,Phase 2,Phase 1 118-42-3 3652
9
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 83-43-2 6741
10
Naltrexone Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2 16590-41-3 5360515
11
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 50-24-8 5755
12
Sulfasalazine Approved Phase 4,Phase 2,Phase 3,Phase 1 599-79-1 5359476 5353980
13
Diclofenac Approved, Vet_approved Phase 4,Phase 3,Phase 2,Early Phase 1 15307-86-5 3033
14
Etoricoxib Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 202409-33-4 123619
15
Certolizumab pegol Approved Phase 4,Phase 3,Phase 2,Phase 1 428863-50-7
16
Menthol Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 2216-51-5 16666
17
Cimetidine Approved, Investigational Phase 4,Phase 3,Phase 2 51481-61-9 2756
18
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 50-02-2 5743
19
Spironolactone Approved Phase 4,Phase 2 1952-01-7, 52-01-7 5833
20
Celecoxib Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 169590-42-5 2662
21
Esomeprazole Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 161796-78-7, 119141-88-7 9579578 4594
22
Naproxen Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 22204-53-1 156391 1302
23
Hyaluronic acid Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 9004-61-9 53477741 24759
24
Dimethyl fumarate Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 624-49-7 5271565 637568
25
Zinc Approved, Investigational Phase 4,Phase 3,Phase 2 7440-66-6 32051 23994
26
Polidocanol Approved Phase 4 9002-92-0
27
Acetaminophen Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 103-90-2 1983
28
Azithromycin Approved Phase 4,Phase 3 83905-01-5 53477736 447043 55185
29
Prednisone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 53-03-2 5865
30
Azathioprine Approved Phase 4,Phase 3,Phase 2 446-86-6 2265
31
Iron Approved Phase 4,Phase 1,Phase 2 7439-89-6 23925
32
Rivaroxaban Approved Phase 4,Phase 3 366789-02-8
33
Tranexamic Acid Approved Phase 4,Phase 3,Phase 2,Phase 1 1197-18-8 5526
34
Tranylcypromine Approved, Investigational Phase 4 155-09-9 441233
35
Bupivacaine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 38396-39-3, 2180-92-9 2474
36
Ropivacaine Approved Phase 4,Phase 3,Phase 2 84057-95-4 175805 71273
37
Denosumab Approved Phase 4,Phase 2,Phase 1 615258-40-7
38
Hyoscyamine Approved Phase 4 101-31-5 64692
39
Milnacipran Approved, Investigational Phase 4 92623-85-3 65833
40
Norepinephrine Approved Phase 4,Phase 3,Phase 2,Phase 1 51-41-2 439260
41
Everolimus Approved Phase 4,Phase 1,Phase 2 159351-69-6 6442177
42
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2 22916-47-8 4189
43
Mycophenolate mofetil Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 128794-94-5 5281078
44
Mycophenolic acid Approved Phase 4,Phase 3,Phase 2,Phase 1 24280-93-1 446541
45
Sirolimus Approved, Investigational Phase 4,Phase 1,Phase 2 53123-88-9 46835353 6436030 5284616
46
Tacrolimus Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2 104987-11-3 445643 439492
47
Calcium Carbonate Approved, Investigational Phase 4,Phase 3,Phase 2 471-34-1
48
Cyclophosphamide Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 50-18-0, 6055-19-2 2907
49
Epinephrine Approved, Vet_approved Phase 4,Phase 3,Phase 2 51-43-4 5816
50
Ketorolac Approved Phase 4,Phase 3,Phase 2 74103-06-3, 66635-83-4 3826

Interventional clinical trials:

(show top 50) (show all 6779)

# Name Status NCT ID Phase Drugs
1 Safety and Efficacy of Gardasil in Females With Juvenile Idiopathic Arthritis (JIA)/Seronegative Arthritis Unknown status NCT00573651 Phase 4
2 Uncontrolled Study to Evaluate Efficacy of Tocilizumab in Patients With Moderate or Severe Rheumatoid Arthritis Unknown status NCT02087696 Phase 4 Tocilizumab
3 Rotation or Change of Biotherapy After First Anti-TNF Treatment Failure for Rheumatoid Arthritis Unknown status NCT01000441 Phase 4 infliximab, etanercept, adalimumab;abatacept, rituximab or tocilizumab
4 Protocol for H.P. Acthar Gel in Moderately to Severely Active Psoriatic Arthritis Unknown status NCT01939132 Phase 4 Open label H.P. Acthar Gel
5 Hanyang University Medical Center Arthritis Network Unknown status NCT00418405 Phase 4
6 Multicenter Randomized Prospective Trial Comparing Methotrexate Alone or in Combination With Adalimumab in Early Arthritis Unknown status NCT00291915 Phase 4 Adalimumab;Methotrexate
7 Effectiveness of Iguratimod Versus Placebo to Treat Early Rheumatoid Arthritis on MRI Unknown status NCT01893151 Phase 4 Iguratimod;Iguratimod placebo
8 Long-term Efficacy of Iguratimod Alone or Iguratimod in Combination With Methotrexate in Patients With Rheumatoid Arthritis Unknown status NCT01548001 Phase 4 Iguratimod;Methotrexate
9 Vaccination Against Pertussis, Tetanus and Diphtheria in Patients Suffering From Rheumatoid Arthritis Unknown status NCT01301703 Phase 4
10 Etanercept and Methotrexate in Patients to Induce Remission in Early Arthritis (EMPIRE) Unknown status NCT01303874 Phase 4 Etanercept (ETN);Placebo
11 The Effect of Biannual Monitoring With Magnetic Resonance Imaging (MRI), X-ray, or Usual Care on Treatment for Inflammatory Arthritis Unknown status NCT00808496 Phase 4
12 Withdrawal of Etanercept After Successful Treatment of Juvenile Idiopathic Arthritis Unknown status NCT01287715 Phase 4 etanercept;etanercept
13 Study of Iguratimod Plus Methotrexate Compared to Leflunomid Plus Methotrexate in Patients With Rheumatoid Arthritis Unknown status NCT02275299 Phase 4 Iguratimod;Leflunomide;Methotrexate
14 TNF-blocking Therapy in Combination With Disease-modifying Antirheumatic Drugs in Early Rheumatoid Arthritis Unknown status NCT00908089 Phase 4 Trexan+Salazopyrin+Oxiklorin+prednisolone + infliximab;Trexan+Salazopyrin+Oxiklorin+prednisolone + placebo
15 Remission Induction in Very Early Rheumatoid Arthritis Unknown status NCT00523692 Phase 4 Etanercept, methotrexate and depomedrone;depemedrone
16 Efficacy Study of Leflunomide to Treat Juvenile Idiopathic Arthritis Unknown status NCT02024334 Phase 4 Leflunomide
17 Targeted Ultrasound in Rheumatoid Arthritis Unknown status NCT02056184 Phase 4 Adalimumab
18 Targeting Synovitis in Early Rheumatoid Arthritis Unknown status NCT00920478 Phase 4
19 Cell Immunity Response to Vaccination Against Influenza in Patients With Rheumatoid Arthritis Unknown status NCT01002716 Phase 4
20 REstore Working Ability in RheumatoiD Arthritis Unknown status NCT01405326 Phase 4
21 Comparison of the Effect of Etoricoxib and Diclofenac on Early Morning Activity in Rheumatoid Arthritis (RA) Unknown status NCT01067430 Phase 4 Etoricoxib;Diclofenac
22 Clinical Study to Evaluate the Efficacy of Anakinra in Patients With Rheumatoid Arthritis and Diabetes Unknown status NCT02236481 Phase 4 Anakinra;TNF alpha inhibitors
23 Heart Function in Rheumatoid Arthritis and Ankylosing Spondylitis Pre and Post-TNF Blocker Unknown status NCT01072058 Phase 4 TNF blockers (infliximab, adalimumab, etanercept)
24 Rheumatoid Arthritis Patients in Training Unknown status NCT00434200 Phase 4
25 Evaluation Effects of Treatment With IL-6R Inhibitor on Clinical Response and Biomarkers in Patients With Rheumatoid Arthritis (RA) Not Responding to DMARDs and/or a First Biological Agent. Unknown status NCT01835613 Phase 4
26 Effects of Biological Treatment on Blood Pressure and Endothelial Function in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Unknown status NCT02132234 Phase 4 Etanercept;Adalimumab;Certolizumab;Infliximab
27 Ultrasonographic Monitoring of Response to Infliximab in Patients With Rheumatoid Arthritis Unknown status NCT01282528 Phase 4
28 Comparison of Adalimumab and Infliximab Treatment of Rheumatoid Arthritis Unknown status NCT00216177 Phase 4 Infliximab;Adalimumab
29 Effect of Tocilizumab to the Cellular Immune Response to Influenza Vaccine Unknown status NCT01980836 Phase 4
30 Bucillamine Study of Holding Remission After Infliximab Dose-off Unknown status NCT00716248 Phase 4 bucillamine;methotrexate
31 Very Early Versus Delayed Etanercept in Patients With RA Unknown status NCT02433184 Phase 4 Etanercept;Methotrexate;Sulfasalazine;Hydroxychloroquine;Etanercept;Methotrexate
32 Efficacy and Safety of Adalimumab 80 mg Every Other Week With Methotrexate Unknown status NCT01270035 Phase 4 Adalimumab
33 Birmingham Hip Resurfacing (BHR) Study: Implantation of a Hip Resurfacing Endoprosthesis Unknown status NCT00180206 Phase 4
34 Gait Analysis of Ankle Arthroplasty and Arthrodesis Unknown status NCT00921076 Phase 4
35 Sensitivity and Specificity of QuantiFeron -TB Gold Test (QFT-G)in Patients With Psoriasis Unknown status NCT01223976 Phase 4
36 Bone Forming at Prosthetic Surfaces. Fingerprint2 Unknown status NCT01623687 Phase 4
37 Corticosteroids as Additive in Temporomandibular Joint (TMJ) Arthrocentesis Unknown status NCT01275014 Phase 4 Dexamethasone;Isotonic saline
38 The Long-term Evaluation of Glucosamine Sulphate Study Unknown status NCT00513422 Phase 4
39 The Post-marketing Surveillance to Evaluate the Efficacy of CHONDRON (Autologous Cultured Chondrocyte) by Arthroscopy Unknown status NCT02539069 Phase 4
40 The Post-marketing Surveillance to Evaluate the Efficacy and Safety of a CHONDRON (Autologous Cultured Chondrocyte) Unknown status NCT02539056 Phase 4
41 The Effect of Spironolactone on Pain in Older People With Osteoarthritis Unknown status NCT02046668 Phase 4 spironolactone
42 Safety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic Diseases Unknown status NCT01151644 Phase 4
43 A Phase 4 Study of Imrecoxib in Treatment of Knee Osteoarthritis Unknown status NCT01985165 Phase 4 Imrecoxib
44 Multi-center Clinical Study of Guli Capsules in the Treatment of Knee Osteoarthritis Unknown status NCT02484508 Phase 4 Guli capsule;Kangguzengsheng capsule
45 Gastro-protective Effect and Pain Relief Effect of Naxozol Compared to Celecoxib in Patients With Osteoarthritis Unknown status NCT02355236 Phase 4 Naproxen/Esomeprazol 500/20mg;Celecoxib 200mg;Naxozol-Placebo;Comparator-Placebo
46 Efficacy of Intra-articular Collagen Injection in Patients With Knee Joint Pain Compared to Normal Saline Injection Unknown status NCT02539095 Phase 4
47 Comparison of Efficacy and Safety of Microfracture and Modified Microfracture Unknown status NCT02539030 Phase 4
48 Validation of a Stress Device for the Knee Unknown status NCT02444663 Phase 4
49 The Effect of Intraaricular Knee Injections of Hyaluronic Acid (HA) on Bone and Cartilaginous Debris, as a Therapeutic Indicator Unknown status NCT00422643 Phase 4 Sodium hyaluronate (hyaluronic acid)
50 The Influence of Adalimumab on Cardiovascular and Metabolic Risk in Psoriasis Unknown status NCT01088165 Phase 4 Adalimumab treatment arm;Fumaric acid esters treatment group

Search NIH Clinical Center for Arthritis

Inferred drug relations via UMLS 69 / NDF-RT 47 :


Cell-based therapeutics:


LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database
Read about Arthritis cell therapies at LifeMap Discovery.
Stem-cell-based therapeutic approaches for Arthritis:
AlloStem
Embryonic/Adult Cultured Cells Related to Arthritis:
Adipose-derived mesenchymal stem cells combined with allograft bone (AlloStem PMIDs: 22500696

Cochrane evidence based reviews: arthritis

Genetic Tests for Arthritis

Genetic tests related to Arthritis:

# Genetic test Affiliating Genes
1 Arthritis 28

Anatomical Context for Arthritis

The Foundational Model of Anatomy Ontology organs/tissues related to Arthritis:

18
Joint, Skin Over The Joint

MalaCards organs/tissues related to Arthritis:

38
Bone, T Cells, Testes, Eye, Skin, Endothelial, Bone Marrow

Publications for Arthritis

Articles related to Arthritis:

(show top 50) (show all 13457)
# Title Authors Year
1
Hyperuricemia in Asian psoriatic arthritis patients. ( 29349920 )
2018
2
Current clinical and bacteriological profile of septic arthritis in young infants: a prospective study from a tertiary referral centre. ( 29427091 )
2018
3
Septic Arthritis of the Wrist. ( 29329124 )
2018
4
Anti-citrullinated alpha enolase antibodies, interstitial lung disease and bone erosion in rheumatoid arthritis. ( 29452423 )
2018
5
Predictors for orthopaedic surgery in patients with rheumatoid arthritis: results from a retrospective cohort study of 1010 patients diagnosed from 1972 to 2009 and followed up until 2015. ( 29447542 )
2018
6
Association of polymorphic variants in IL1B gene with secretion of IL-1I^ protein and inflammatory markers in north Indian rheumatoid arthritis patients. ( 29054755 )
2018
7
Evaluation of Self-reported Patient Experiences: Insights from Digital Patient Communities in Psoriatic Arthritis. ( 29449495 )
2018
8
Bacteremia and Septic Arthritis due to a Nontoxigenic Strain of<i>Clostridium difficile</i>in a Patient With Sickle Cell Disease. ( 29410974 )
2018
9
Novel UNC13D intronic variant disrupting a NFI_B enhancer in a patient with recurrent macrophage activation syndrome and systemic juvenile idiopathic arthritis. ( 29409136 )
2018
10
Secukinumab for the maintenance of glucocorticoid-free remission in a patient with giant cell arteritis and psoriatic arthritis. ( 29394408 )
2018
11
Early hearing loss detection in rheumatoid arthritis and primary SjAPgren syndrome using extended high frequency audiometry. ( 29273832 )
2018
12
The effect of non anti TNF targeting biologics and small molecules on insulin resistance in inflammatory arthritis. ( 29452240 )
2018
13
Physiotherapists' management of challenging situations in guiding people with rheumatoid arthritis to health-enhancing physical activity. ( 29447492 )
2018
14
Risk-factor analysis of adjacent segment disease requiring surgery after short lumbar fusion: the influence of rheumatoid arthritis. ( 29452286 )
2018
15
Gut Microbiota Perturbations in Reactive Arthritis and Postinfectious Spondyloarthritis. ( 29073348 )
2018
16
Oral Biofilms from Symbiotic to Pathogenic Interactions and Associated Disease -Connection of Periodontitis and Rheumatic Arthritis by Peptidylarginine Deiminase. ( 29441048 )
2018
17
Neutrophils: Beneficial and Harmful Cells in Septic Arthritis. ( 29401737 )
2018
18
Standards of care and quality indicators for multidisciplinary care models for psoriatic arthritis in Spain. ( 29417210 )
2018
19
Drug survival and effectiveness of ustekinumab in patients with psoriatic arthritis. Real-life data from the biologic Apulian registry (BIOPURE). ( 29411182 )
2018
20
Spondyloarthritis: Which composite measures to use in psoriatic arthritis? ( 29416138 )
2018
21
Psoriatic arthritis screening by the dermatologist: development and first validation of the "PURE-4 scale". ( 29430720 )
2018
22
Septic arthritis caused by Granulicatella adiacens after anterior cruciate ligament reconstruction. ( 29422445 )
2018
23
The DNA methylation landscape of CD4<sup>+</sup>T cells in oligoarticular juvenile idiopathic arthritis. ( 28969936 )
2018
24
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade. ( 29426067 )
2018
25
Predictors of revision, prosthetic joint infection and mortality following total hip or total knee arthroplasty in patients with rheumatoid arthritis: a nationwide cohort study using Danish healthcare registers. ( 29097373 )
2018
26
LncRNA ZFAS1 promotes cell migration and invasion of fibroblast-like synoviocytes by suppression of miR-27a in rheumatoid arthritis. ( 28721682 )
2018
27
Chronic reactive arthritis associated with prostatitis caused by<i>Neisseria meningitidis</i>. ( 29374652 )
2018
28
The anti-CD6 antibody itolizumab provides clinical benefit without lymphopenia in rheumatoid arthritis patients: results from a 6-month, open-label Phase I clinical trial. ( 28963724 )
2018
29
Validating an Algorithm to Predict Adjacent Musculoskeletal Infections in Pediatric Patients With Septic Arthritis. ( 29389760 )
2018
30
Neutralization of TNFR-1 and TNFR-2 modulates S. aureus induced septic arthritis by regulating the levels of pro inflammatory and anti inflammatory cytokines during the progression of the disease. ( 29339199 )
2018
31
The association between caspase-5 gene polymorphisms and rheumatoid arthritis in a Chinese population. ( 29158166 )
2018
32
Emergence and treatment of chikungunya arthritis. ( 29389830 )
2018
33
Repository corticotropin injection in patients with rheumatoid arthritis resistant to biologic therapies. ( 29445306 )
2018
34
Assessment of effectiveness and safety of biosimilar infliximab (CT-P13) in a real-life setting for treatment of patients with active rheumatoid arthritis or ankylosing spondylitis. ( 29439591 )
2018
35
Acute inflammatory arthritis: Methotrexate for chronic chikungunya arthritis? ( 29416137 )
2018
36
Patient Factors Associated With Methicillin-Resistant Staphylococcus aureus Septic Arthritis in Children. ( 29451940 )
2018
37
Arthritis and use of hydroxychloroquine associated with a decreased risk of macrophage activation syndrome among adult patients hospitalized with systemic lupus erythematosus. ( 29451069 )
2018
38
A review of ustekinumab in the treatment of psoriatic arthritis. ( 29439608 )
2018
39
Potential risk factors for reactive arthritis and persistence of symptoms at 2A years: a case-control study with longitudinal follow-up. ( 29139030 )
2018
40
Patient-reported Outcomes, Resource Use, and Social Participation of Patients with Rheumatoid Arthritis Treated with Biologics in Alberta: Experience of Indigenous and Non-indigenous Patients. ( 29449496 )
2018
41
Neutrophil Microvesicles from Healthy Control and Rheumatoid Arthritis Patients Prevent the Inflammatory Activation of Macrophages. ( 29449195 )
2018
42
Several high-resolution computed tomography findings associate with survival and clinical features in rheumatoid arthritis-associated interstitial lung disease. ( 29413504 )
2018
43
Isolated Bicipito-radial Bursitis in a Patient With Rheumatoid Arthritis. ( 29280830 )
2018
44
Role of the IL-23/IL-17 Axis in Psoriasis and Psoriatic Arthritis: The Clinical Importance of Its Divergence in Skin and Joints. ( 29425183 )
2018
45
Association of heterogeneity of the thyroid gland with matrix metalloproteinase-3 in rheumatoid arthritis patients with Hashimoto's thyroiditis. ( 29442475 )
2018
46
Rheumatologists' Views and Experiences in Managing Rheumatoid Arthritis in Elderly Patients: A Qualitative Study. ( 29449497 )
2018
47
Effect of Biologics on Fatigue in Psoriatic Arthritis: A Systematic Literature Review with Meta-analysis. ( 29452303 )
2018
48
A new assessment tool for ulnar drift in patients with rheumatoid arthritis using pathophysiological parameters of the metacarpophalangeal joint. ( 29448870 )
2018
49
Arthroscopic surgery for degenerative knee arthritis and meniscal tears: a clinical practice guideline. ( 29449218 )
2018
50
The relationship between depression and biologic treatment response in rheumatoid arthritis: An analysis of the British Society for Rheumatology Biologics Register. ( 29447376 )
2018